Jack Bikker - Concepedia

Author

Jack Bikker

Pearl River Community College

Also Known As

J A Bikker, J Bikker, J. A. BIKKER, J. A. Bikker, Jack A Bikker, Jack A. Bikker, Jack Andrew Bikker, Jack Bikker

Publications

Citations

H-Index

Concepts

All Affiliations

Pearl River Community College Pfizer (United States)International Flavors & Fragrances (United States)University of Cambridge Queen's University

About

Jack Bikker is an author at Pearl River Community College specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	445
2	Natural Sciences	7	7	396
3	Biochemistry	6	6	186
4	Biomolecular Engineering	2	2	73
5	Engineering	1	1	14

Jack Bikker

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success Frank Lovering, Jack Bikker, Christine Humblet Journal of Medicinal Chemistry	2009	4.2K
Kinase Domain Mutations in Cancer: Implications for Small Molecule Drug Design Strategies Jack Bikker, Natasja Brooijmans, Allan Wissner, Journal of Medicinal Chemistry Drug TargetAltmetric Attention ScoreMolecular BiologyPathologyTumor Biology	2009	159
Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists. Carrie Haskell‐Luevano, Tomi K. Sawyer, Susanne Trumpp-Kallmeyer, PubMed Electron Density FootprintHmc1r ModelMolecular BiologyMelanotropin Peptide AgonistsChemical Biology	1996	67
Site Selection: a Case Study in the Identification of Optimal Cysteine Engineered Antibody Drug Conjugates L. Nathan Tumey, Fengping Li, Brian Rago, The AAPS Journal Drug TargetDrug DesignDrug DiscoveryNatural SciencesMedicine	2017	63
Design and biological evaluation of non-peptide analogues of omega-conotoxin MVIIA Stefan Menzler, Jack Bikker, Nirmala Suman‐Chauhan, Bioorganic & Medicinal Chemistry Letters Bioorganic ChemistryBiochemistryOmega-conotoxin MviiaNatural SciencesMedicine	2000	48
Development of QSAR models for microsomal stability: identification of good and bad structural features for rat, human and mouse microsomal stability Yongbo Hu, Ray Unwalla, R. Aldrin Denny, Journal of Computer-Aided Molecular Design Knockout MouseQsar ModelsMicrosomal StabilityMedicineBad Structural Features	2009	48
PF-06804103, A Site-specific Anti-HER2 Antibody–Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung Cancers Edmund I. Graziani, Matthew Sung, Dangshe Ma, Molecular Cancer Therapeutics	2020	45
Two classes of structurally different antagonists display similar species preference for the human tachykinin neurokinin3 receptor. Fu‐Zon Chung, Liang-Chun Wu, Yuan Tian, Molecular Pharmacology	1995	42
Direct Oxa-Pictet−Spengler Cyclization to the Natural (3a,5)-<i>trans</i>-Stereochemistry in the Syntheses of (+)-7-Deoxyfrenolicin B and (+)-7-Deoxykalafungin Clark N. Eid, Jaechul Shim, Jack Bikker, The Journal of Organic Chemistry	2008	41
Synthesis of a non-peptide analogue of omega-conotoxin MVIIA Stefan Menzler, Jack Bikker, David C. Horwell Tetrahedron Letters Bioorganic ChemistryBiochemistryOmega-conotoxin MviiaNatural SciencesPeptide Synthesis	1998	30

Page 1